HealthDay (7/7, Murez) reported, “Americans who engage in creative activities – from crafting to playing the piano to painting — report better mental health, according to” findings from a 2,202-adult Healthy Minds Monthly Poll conducted in June by the American Psychiatric Association and announced in a July 6 news release. In that release, APA President Petros Levounis, MD, MA, stated, “Creative activities aren’t just for fun, they can help us take a step back from the daily grind, use our brains differently, and relax,” and “picking up that paintbrush or solving a tricky puzzle can truly move us to a different mindset.” APA CEO and Medical Director Saul Levin, MD, MPA, said, “APA is pleased to call attention to these positive actions as part of the public discussion on mental health.”

Related Links:

— “Expressing Yourself Creatively Gives Mental Health Boost, Poll Finds,”Cara Murez, HealthDay, July 7, 2023

According to the New York Times (7/9, Span), “as baby boomers have turned 65, the age at which they typically qualify for Medicare, substance use disorders among the older population have climbed steeply.” For instance, “a study of opioid use disorder in people over 65 enrolled in traditional Medicare” published in a research brief in the June 2021 issue of the American Journal of Preventive Medicine, “showed a threefold increase in just five years – to 15.7 cases per 1,000 in 2018 from 4.6 cases per 1,000 in 2013.” Additionally, “fatal overdoses have…soared among seniors,” according to the findings of a research letter published online March 29 in JAMA Psychiatry.

Related Links:

— “Substance Abuse Is Climbing Among Seniors,”Paula Span, The New York Times, July 9, 2023

The New York Times (7/6, Belluck) reports the FDA granted “full approval to the Alzheimer’s drug Leqembi (lecanemab), and Medicare said it would cover much of its high cost, laying the foundation for widespread use of a medication that can modestly slow cognitive decline in the early stages of the disease but also carries significant safety risks.” The agency’s “decision marks the first time in two decades that a drug for Alzheimer’s has received full approval, meaning that the agency concluded there is solid evidence of potential benefit.” However, the FDA “also added a so-called black-box warning…stating that in rare cases the drug can cause ‘serious and life-threatening events.’”

Reuters (7/6, Beasley, Steenhuysen) reports the drug, “which is given intravenously, has a U.S. list price of $26,500 per year.” The “new label explains the need to monitor patients for potentially dangerous brain swelling and bleeding associated with amyloid-lowering antibodies.” Additionally, “the drug’s new label includes data showing that the use of certain anti-coagulants with Leqembi has been linked to a risk of brain hemorrhage.”

Related Links:

— “New Federal Decisions Make Alzheimer’s Drug Leqembi Widely Accessible,”Pam Belluck, The New York Times , July 6, 2023

MedPage Today (7/6, Putka) reports, “Adults with cannabis use disorder had a moderately increased risk of morbidity and in-hospital mortality after major elective surgery compared with those without cannabis use disorder, a large retrospective study found.” Data show that “among 12,422 hospitalized patients, a composite outcome of perioperative complications and mortality occurred in 7.73% of the cannabis use disorder group and 6.57% of a matched control group.” The findings were published online in JAMA Surgery.

Related Links:

— MedPage Today (requires login and subscription)

HealthDay (7/6, Norton) reports, “Loneliness might be a true heartbreaker for people with diabetes – raising their odds of a heart attack even more than unhealthy lifestyle habits do,” according to findings from “a new study of over 18,000 adults with the blood sugar disease” published online in the European Heart Journal. The study team “found that people who reported feeling lonely were up to 26% more likely to suffer a heart attack or stroke in the next decade, compared to those who felt more socially connected.”

Related Links:

— “Loneliness Can Really Break a Heart in People With Diabetes,”Amy Norton, HealthDay, July 6, 2023

Healio (7/6, Young) reports, “Depression associated with hormonal contraception” (HC) “may indicate susceptibility to postpartum depression,” investigators concluded in findings published online April 26 in JAMA Psychiatry. In the “study of 188,648 first-time mothers, 5,722 (mean age, 26.7 years) had a history of depression associated with HC use and 18,431 (mean age, 27.1 years) had a history of depression not associated with HC.” The study revealed that “women with depression associated with HC initiation had a higher risk for postpartum depression.”

Related Links:

— “Depression associated with hormonal contraception indicates risk for postpartum depression,”Kate Young, Healio, July 6, 2023

Healio (7/5, Weldon) reports, “The FDA said Wednesday that it has warned six companies about illegally selling what it called ‘copycat’ edibles containing delta-8 tetrahydrocannabinol” (delta-8 THC), “a psychoactive and intoxicating substance found in cannabis sativa plants.” The substance “has not been approved by the FDA for any safe use.” In a July 5 press release, the agency “said the copycat products – often designed to resemble snack foods such as chips, cookies, candy and gummies – could be accidentally consumed by children in large quantities without realizing it.”

Related Links:

— “FDA warns companies about illegally selling ‘copycat’ edibles with delta-8 THC,”Rose Weldon, Healio, July 5, 2023

According to MedPage Today (7/5, DePeau-Wilson), for children with attention-deficit/hyperactivity disorder (AD/HD), “use of prescription stimulant medication to manage their symptoms was not associated with later substance use,” investigators concluded in a “longitudinal analysis” that “followed patients with” AD/HD “over a 16-year period from childhood through adolescence into early adulthood.” The findings of the 547-child study were published online July 5 in JAMA Psychiatry.

Related Links:

— MedPage Today (requires login and subscription)

The New York Times (7/5, Abelson) reports, “People with private Medicare coverage may not be getting the mental health services they need because they cannot find a psychiatrist within their plan’s network,” investigators concluded in findings published online July 5 in the journal Health Affairs. The study revealed that “more than half of the counties…studied did not have a single psychiatrist participating in a Medicare Advantage plan, the private-sector counterpart to traditional Medicare.” Psychiatrists “may be unwilling to participate in Medicare Advantage plans because of the low payments paid by the insurers, coupled with all of the required paperwork, said” Robert Trestman, MD, PhD, who chairs “the council on health care systems and financing for the American Psychiatric Association.” Dr. Trestman said, “Many of the challenges and frustrations are emphasized in the Medicare Advantage plans.”

Related Links:

— “Medicare Advantage Plans Offer Few Psychiatrists,” Reed Abelson, The New York Times, July 5, 2023

CNN (7/4, McPhillips) reports, “Residents of 12 states in the South and Midwest are more likely to smoke – and to smoke more – than people living in the rest of the United States, according to a new report” from the nonprofit Truth Initiative, which “has dubbed that group of states ‘Tobacco Nation,’ a region that spans Alabama, Arkansas, Indiana, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Ohio, Oklahoma, Tennessee and West Virginia.” CNN adds, “Overall, smoking prevalence is about 50% higher there than in the rest of the U.S.”

Related Links:

— “The 12 states where smoking is 50% more common than in the rest of the US,”Deidre McPhillips, CNN, July 4, 2023